DOX Stock Analysis: Amdocs | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 6.081m USD | 12M Return: -31.1% | GB0022569080 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 70.1M
EPS Trend: 98.0%
Qual. Beats: 1
Rev. Trend: -84.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Amdocs Limited (NASDAQ: DOX) provides software and services to communications, entertainment, media, and other service providers worldwide. The company designs, develops, operates, implements, supports, and markets an open and modular cloud offering. It also offers CES25, a telco-native, GenAI-led customer experience suite spanning business, operations, and network domains, along with a portfolio that includes the Customer Engagement Platform, Amdocs Monetization Suite, Amdocs Intelligent Networking Suite, Amdocs Charging, Amdocs eSIM Cloud, Amdocs MarketONE, Amdocs connectX, and Amdocs CatalogONE.
In addition, Amdocs provides consulting, experience design, data, cloud, network services, delivery, quality engineering, systems integration, and content services, as well as maintenance, enhancement, operational support, network deployment and optimization, and managed services featuring AI tools, predictive analytics, and robotic process automation. The company was founded in 1982 and is headquartered in Saint Louis, Missouri.
Amdocs operates in the IT Consulting & Other Services sub-industry within the Information Technology sector, focusing on B2B software and services sold primarily to telecom and media operators. Its offerings include both perpetual/on-premise software and SaaS-based platforms, such as Amdocs MarketONE and connectX, aligning with the broader industry shift toward cloud-native, subscription-based delivery models.
- Telecom operator capex cuts weigh on services revenue
- CES25 GenAI suite adoption accelerates digital transformation deals
- Aggressive share buybacks boost earnings per share growth
| Net Income: 454.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.13 > 1.0 |
| NWC/Revenue: -2.36% < 20% (prev 6.47%; Δ -8.83% < -1%) |
| CFO/TA 0.12 > 3% & CFO 748.8m > Net Income 454.7m |
| Net Debt (760.2m) to EBITDA (847.2m): 0.90 < 3 |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.7m) vs 12m ago -4.94% < -2% |
| Gross Margin: 37.81% > 18% (prev 37.24%; Δ 0.58% > 0.5%) |
| Asset Turnover: 73.00% > 50% (prev 73.38%; Δ -0.38% > 0%) |
| Interest Coverage Ratio: 14.78 > 6 (EBIT TTM 638.0m / Interest Expense TTM 43.2m) |
| A: -0.02 (Total Current Assets 1.59b - Total Current Liabilities 1.70b) / Total Assets 6.42b |
| B: 1.12 (Retained Earnings 7.16b / Total Assets 6.42b) |
| C: 0.10 (EBIT TTM 638.0m / Avg Total Assets 6.37b) |
| D: 1.06 (Book Value of Equity 3.29b / Total Liabilities 3.09b) |
| Altman-Z'' = 5.32 = AAA |
| DSRI: 1.05 (Receivables 1.01b/956.6m, Revenue 4.65b/4.65b) |
| GMI: 0.98 (GM 37.24% / 37.81%) |
| AQI: 1.04 (AQ_t 0.61 / AQ_t-1 0.59) |
| SGI: 1.00 (Revenue 4.65b / 4.65b) |
| TATA: -0.05 (NI 454.7m - CFO 748.8m) / TA 6.42b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of August 17, 2026, the stock is trading at USD 58.22 with a total of 803,965 shares traded. Over the past week, the price has changed by -0.56%, over one month by +12.05%, over three months by -4.94% and over the past year by -31.12%.
Current recommended Stop Loss: 55.60 (which is 4.5% or 1.4 ATR below the current price).
Amdocs has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy DOX.
- StrongBuy: 3
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 81.2 | 39.5% |
P/E Trailing = 13.829
P/E Forward = 7.0721
P/S = 1.3328
P/B = 1.8936
P/EG = 0.7857
Revenue TTM = 4.65b USD
EBIT TTM = 638.0m USD
EBITDA TTM = 847.2m USD
Long Term Debt = 647.4m USD (from longTermDebt, last quarter)
Short Term Debt = 314.7m USD (from shortTermDebt, last quarter)
Debt = 966.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 159.6m
Net Debt = 760.2m USD (calculated: Debt 966.7m - CCE 206.5m)
Enterprise Value = 6.84b USD (6.08b + Debt 966.7m - CCE 206.5m)
Interest Coverage Ratio = 14.78 (Ebit TTM 638.0m / Interest Expense TTM 43.2m)
EV/FCF = 10.71x (Enterprise Value 6.84b / FCF TTM 638.8m)
FCF Yield = 9.34% (FCF TTM 638.8m / Enterprise Value 6.84b)
FCF Margin = 13.73% (FCF TTM 638.8m / Revenue TTM 4.65b)
Net Margin = 9.77% (Net Income TTM 454.7m / Revenue TTM 4.65b)
Gross Margin = 37.81% ((Revenue TTM 4.65b - Cost of Revenue TTM 2.89b) / Revenue TTM)
Gross Margin QoQ = 39.76% (prev 37.04%)
Tobins Q-Ratio = 1.07 (Enterprise Value 6.84b / Total Assets 6.42b)
Interest Expense / Debt = 4.46% (Interest Expense 43.2m / Debt 966.7m)
Taxrate = 21.59% (126.0m / 583.5m)
NOPAT = 500.2m (EBIT 638.0m * (1 - 21.59%))
Current Ratio = 0.94 (Total Current Assets 1.59b / Total Current Liabilities 1.70b)
Debt / Equity = 0.29 (Debt 966.7m / totalStockholderEquity, last quarter 3.29b)
Debt / EBITDA = 0.90 (Net Debt 760.2m / EBITDA 847.2m)
Debt / FCF = 1.19 (Net Debt 760.2m / FCF TTM 638.8m)
Total Stockholder Equity = 3.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.13% (Net Income 454.7m / Total Assets 6.42b)
RoE = 13.45% (Net Income TTM 454.7m / Total Stockholder Equity 3.38b)
RoCE = 15.84% (EBIT 638.0m / Capital Employed (Equity 3.38b + L.T.Debt 647.4m))
RoIC = 10.37% (NOPAT 500.2m / Invested Capital 4.82b)
WACC = 6.72% (E(6.08b)/V(7.05b) * Re(7.23%) + D(966.7m)/V(7.05b) * Rd(4.46%) * (1-Tc(0.22)))
Discount Rate = 7.23% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.59 | Cagr: -4.46%
[DCF] Terminal Value 75.44% ; FCFF base≈638.8m ; Y1≈641.6m ; Y5≈680.0m
[DCF] Fair Price = 92.46 (EV 10.6b - Net Debt 760.2m = Equity 9.82b / Shares 106.2m; r=8.35% [WACC [floored]]; 5y FCF grow 0.03% → 2.50% )
EPS Correlation: 98.01 | EPS CAGR: 7.99% | SUE: 1.15 | # QB: 1
Revenue Correlation: -84.27 | Revenue CAGR: -3.36% | SUE: 0.27 | # QB: 0
EPS current Quarter (2026-12-31): EPS=1.93 | Chg30d=-1.28% | Revisions=+25% | Analysts=4
EPS current Year (2026-09-30): EPS=7.42 | Chg30d=+0.11% | Revisions=+0% | GrowthEPS=+6.1% | GrowthRev=+3.6%
EPS next Year (2027-09-30): EPS=8.03 | Chg30d=-0.46% | Revisions=+50% | GrowthEPS=+8.2% | GrowthRev=+3.3%
[Analyst] Revisions Ratio: +44% (up=5, down=1)